Advantages of brain penetrating inhibitors of kynurenine-3-monooxygenase for treatment of neurodegenerative diseases. (2021)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.abb.2020.108702
PubMed Identifier: 33275878
Publication URI: http://europepmc.org/abstract/MED/33275878
Type: Journal Article/Review
Volume: 697
Parent Publication: Archives of biochemistry and biophysics
ISSN: 0003-9861